BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17096327)

  • 21. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.
    Gray SG; Al-Sarraf N; Baird AM; Gately K; McGovern E; O'Byrne KJ
    Clin Lung Cancer; 2008 Nov; 9(6):367-74. PubMed ID: 19073520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion mapping of chromosome 2 in human lung carcinoma.
    Otsuka T; Kohno T; Mori M; Noguchi M; Hirohashi S; Yokota J
    Genes Chromosomes Cancer; 1996 Jun; 16(2):113-9. PubMed ID: 8818658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history.
    Eguchi K; Kanai Y; Kobayashi K; Hirohashi S
    Cancer Res; 1997 Nov; 57(21):4913-5. PubMed ID: 9354457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
    Shipman R; Schraml P; Colombi M; Ludwig CU
    Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
    Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
    Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients.
    Adnane J; Muro-Cacho C; Mathews L; Sebti SM; Muñoz-Antonia T
    Clin Cancer Res; 2002 Jul; 8(7):2225-32. PubMed ID: 12114424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications.
    Gray SG; Al-Sarraf N; Baird AM; Cathcart MC; McGovern E; O'Byrne KJ
    Eur J Cancer; 2009 Nov; 45(17):3087-97. PubMed ID: 19818596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METH-2 silencing and promoter hypermethylation in NSCLC.
    Dunn JR; Panutsopulos D; Shaw MW; Heighway J; Dormer R; Salmo EN; Watson SG; Field JK; Liloglou T
    Br J Cancer; 2004 Sep; 91(6):1149-54. PubMed ID: 15328519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition.
    Bousquet E; Calvayrac O; Mazières J; Lajoie-Mazenc I; Boubekeur N; Favre G; Pradines A
    Oncogene; 2016 Apr; 35(14):1760-9. PubMed ID: 26148238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
    Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
    Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.